S&P 500   4,205.45
DOW   33,093.34
QQQ   348.40
10 Ways Entrepreneurs Can Navigate a Down Economy
How to Invest in AI's Fast-Growing Market (Ad)
Get the Most Out of Remote Meetings and Avoid Meeting Burn Out
A Woman Co-founder's Guide to Empowering Women in the Workplace and Advocating for Gender Equality
How to Invest in AI's Fast-Growing Market (Ad)
Open vs. Anonymous Employee Feedback — Which is Better?
South African president appoints judge to oversee weapons-for-Russia inquiry
The Largest Ever Technology Wave Is Coming! (Ad)
3 Cheap (and Tax-Free) Dividends That Love Debt-Ceiling Drama
Poland imposes sanctions on 365 Belarusians over 'draconian' verdict against journalist
S&P 500   4,205.45
DOW   33,093.34
QQQ   348.40
10 Ways Entrepreneurs Can Navigate a Down Economy
How to Invest in AI's Fast-Growing Market (Ad)
Get the Most Out of Remote Meetings and Avoid Meeting Burn Out
A Woman Co-founder's Guide to Empowering Women in the Workplace and Advocating for Gender Equality
How to Invest in AI's Fast-Growing Market (Ad)
Open vs. Anonymous Employee Feedback — Which is Better?
South African president appoints judge to oversee weapons-for-Russia inquiry
The Largest Ever Technology Wave Is Coming! (Ad)
3 Cheap (and Tax-Free) Dividends That Love Debt-Ceiling Drama
Poland imposes sanctions on 365 Belarusians over 'draconian' verdict against journalist
S&P 500   4,205.45
DOW   33,093.34
QQQ   348.40
10 Ways Entrepreneurs Can Navigate a Down Economy
How to Invest in AI's Fast-Growing Market (Ad)
Get the Most Out of Remote Meetings and Avoid Meeting Burn Out
A Woman Co-founder's Guide to Empowering Women in the Workplace and Advocating for Gender Equality
How to Invest in AI's Fast-Growing Market (Ad)
Open vs. Anonymous Employee Feedback — Which is Better?
South African president appoints judge to oversee weapons-for-Russia inquiry
The Largest Ever Technology Wave Is Coming! (Ad)
3 Cheap (and Tax-Free) Dividends That Love Debt-Ceiling Drama
Poland imposes sanctions on 365 Belarusians over 'draconian' verdict against journalist
S&P 500   4,205.45
DOW   33,093.34
QQQ   348.40
10 Ways Entrepreneurs Can Navigate a Down Economy
How to Invest in AI's Fast-Growing Market (Ad)
Get the Most Out of Remote Meetings and Avoid Meeting Burn Out
A Woman Co-founder's Guide to Empowering Women in the Workplace and Advocating for Gender Equality
How to Invest in AI's Fast-Growing Market (Ad)
Open vs. Anonymous Employee Feedback — Which is Better?
South African president appoints judge to oversee weapons-for-Russia inquiry
The Largest Ever Technology Wave Is Coming! (Ad)
3 Cheap (and Tax-Free) Dividends That Love Debt-Ceiling Drama
Poland imposes sanctions on 365 Belarusians over 'draconian' verdict against journalist
TSE:KPT

KP Tissue (KPT) Earnings Date, Estimates & Call Transcripts

C$10.34
+0.03 (+0.29%)
(As of 05/29/2023 ET)
Compare
Today's Range
C$10.34
C$10.34
50-Day Range
C$10.14
C$10.45
52-Week Range
C$10.04
C$11.22
Volume
300 shs
Average Volume
7,071 shs
Market Capitalization
C$102.88 million
P/E Ratio
N/A
Dividend Yield
6.96%
Price Target
C$10.38

Earnings Summary

Upcoming
Earnings Date
Aug. 10Estimated
Actual EPS
(Mar. 9)
-C$0.10 Missed By -C$0.09
Consensus EPS
(Mar. 9)
-C$0.01
Last Year's Q1 EPS
(3/10/2022)
C$0.35
Skip Charts & View Estimated and Actual Earnings Data

KPT Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

KPT Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

KP Tissue Analyst Forecasts

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20231C($0.01)C($0.01)C($0.01)
Q2 20231C$0.00C$0.00C$0.00
Q3 20231C$0.03C$0.03C$0.03
Q4 20231C$0.05C$0.05C$0.05
FY 20234C$0.07C$0.07C$0.07

KPT Earnings Date and Information

KP Tissue last announced its earnings results on March 9th, 2023. The reported C($0.10) earnings per share (EPS) for the quarter, missing the consensus estimate of C($0.01) by C$0.09. The firm had revenue of C$458.14 million for the quarter, compared to the consensus estimate of C$443 million. KP Tissue has generated C($2.20) earnings per share over the last year (C($2.20) diluted earnings per share). KP Tissue has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, August 10th, 2023 based off prior year's report dates.

KP Tissue Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
8/10/2023
(Estimated)
        
3/9/2023Q4 2022C($0.01)C($0.10)C($0.09)C($0.10)C$443.00 millionC$458.14 million
11/9/2022Q3 2022C($0.13)C($0.63)C($0.50)C($0.63)C$423.00 millionC$427.03 million
8/11/2022Q2 2022C($0.19)C($0.40)C($0.21)C($0.40)C$417.25 millionC$397.50 million
5/12/2022Q1 2022C($0.07)C$0.10+C$0.17C$0.10C$408.45 millionC$398.74 million
3/10/2022Q4 2021C$0.03C$0.35+C$0.32C$0.35C$385.20 millionC$424.03 million
11/12/2021Q3 2021C$0.07C($0.23)C($0.30)C($0.23)C$378.00 millionC$391.39 million
8/12/2021Q2 2021C$0.08C($0.13)C($0.21)C($0.13)C$360.70 millionC$339.36 million
5/7/2021Q1 2021C$0.09C$0.12+C$0.03C$0.12C$353.30 millionC$310.38 million
3/11/2021Q4 2020C$0.18C($0.44)C($0.62)C($0.44)C$350.45 millionC$384.97 million
11/5/2020Q3 2020C$0.30C$0.08C($0.22)C$0.08C$357.15 millionC$369.10 million
8/6/2020Q2 2020C$0.19C($0.01)C($0.20)C($0.01)C$369.05 millionC$386.76 million
5/8/2020Q1 2020C$0.16C$0.18+C$0.02C$0.18C$345.70 millionC$375.15 million
3/12/2020Q4 2019C$0.19C($0.17)C($0.36)C($0.17)
11/7/2019Q3 2019C$0.13C($0.04)C($0.17)C($0.04)C$369.70 millionC$369.36 million
8/8/2019Q2 2019C$0.03C$0.02C($0.01)C$0.31C$362.00 millionC$365.67 million
3/7/2019Q4 2018C$0.06C$0.30+C$0.24C$0.30
11/8/2018Q3 2018C$0.10C($0.09)C($0.19)C($0.09)
8/9/2018Q2 2018C$0.08C$0.08C$0.30
5/10/2018Q1 2018C$0.10C($0.09)C($0.19)C($0.09)C$292.60 million
3/8/2018Q4 2017C($0.46)C($0.46)C($0.46)
11/8/2017Q3 2017C($0.01)C($0.01)C($0.01)
8/9/2017Q2 2017C($0.06)C($0.06)C($0.06)
5/4/2017Q1 2017C($0.06)C($0.06)C($0.06)
3/9/2017Q4 2016C($0.04)C($0.04)C($0.04)
11/3/2016Q3 2016C$0.22C$0.08C($0.14)C$0.08
8/10/2016Q2 2016C$0.15C($0.07)C($0.22)C($0.07)
5/5/2016Q1 2016C$0.17C($0.16)C($0.33)C($0.16)
3/10/2016Q4 2015C$0.16C$0.01C($0.15)C$3.14
11/11/2015Q3 2015C$0.08C($0.22)C($0.30)C($0.22)
8/12/2015Q2 2015C$0.13C($0.11)C($0.24)C($0.11)C$300.00 million  
5/7/2015Q1 2015C$0.15C($0.07)C($0.22)C($0.07)
3/12/2015Q4 2014C$0.21C($0.14)C($0.35)C($0.14)
11/12/2014Q3 2014C$0.08+C$0.08C$0.08
8/13/2014Q2 2014C($0.03)C($0.03)C($0.03)
5/9/2014Q1 2014C$0.14C($0.19)C($0.33)C($0.19)
3/19/2014Q4 2013C$0.22C($0.08)C($0.30)C($0.08)
11/13/2013Q3 2013C$0.20C$0.06C($0.14)C$0.06
8/13/2013Q2 2013C$0.14C$0.07C($0.07)C$0.07
5/14/2013Q1 2013C($0.08)C($0.08)C($0.08)












KP Tissue Earnings - Frequently Asked Questions

When is KP Tissue's earnings date?

KP Tissue has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, August 10th, 2023 based off last year's report dates. Learn more on KPT's earnings history.

Did KP Tissue beat their earnings estimates last quarter?

In the previous quarter, KP Tissue (TSE:KPT) missed the analysts' consensus estimate of C($0.01) by C$0.09 with a reported earnings per share (EPS) of C($0.10). Learn more on analysts' earnings estimate vs. KPT's actual earnings.

How much profit does KP Tissue generate each year?

KP Tissue (TSE:KPT) has a recorded net income of -C$21.91 million. KPT has generated -C$2.20 earnings per share over the last four quarters.

What is KP Tissue's price-to-earnings ratio?

KP Tissue (TSE:KPT) has a forward price-to-earnings ratio of 36.76. The price/earnings-to-growth ratio is -0.88.

More Earnings Resources from MarketBeat

This page (TSE:KPT) was last updated on 5/30/2023 by MarketBeat.com Staff

My Account -